medroxyprogesterone acetate has been researched along with Bone Demineralization, Pathologic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachrach, LK; Gold, MA | 1 |
| Bonny, A; Cromer, BA; Debanne, SM; Lazebnik, R; Rome, E; Stager, M; Ziegler, J | 1 |
| Wooltorton, E | 1 |
3 other study(ies) available for medroxyprogesterone acetate and Bone Demineralization, Pathologic
| Article | Year |
|---|---|
Contraceptive use in teens: a threat to bone health?
Topics: Adolescent; Adolescent Health Services; Bone Demineralization, Pathologic; Bone Density; Bone Development; Clinical Trials as Topic; Contraception Behavior; Contraceptive Agents, Female; Female; Health Education; Humans; Medroxyprogesterone Acetate; Pregnancy; Pregnancy in Adolescence; Risk Factors; United States | 2004 |
Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls.
Topics: Absorptiometry, Photon; Adolescent; Adolescent Health Services; Body Mass Index; Bone Demineralization, Pathologic; Bone Density; Bone Development; Cohort Studies; Confidence Intervals; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Ethinyl Estradiol; Female; Femur Neck; Health Education; Humans; Levonorgestrel; Lumbar Vertebrae; Medroxyprogesterone Acetate; Odds Ratio; Prospective Studies; Risk Factors; Time Factors; United States | 2004 |
Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss.
Topics: Adult; Bone Demineralization, Pathologic; Bone Density; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone Acetate; Osteoporosis | 2005 |